Neuroprotective Mechanisms of Salidroside in Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies
Journal of Agricultural and Food Chemistry · 2023
DOI: 10.1021/acs.jafc.3c06672 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Agricultural and Food Chemistry, 2023. Verfasst von Nan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seventh Clinical College of China Medical University, 24 Central Street, Xinfu District, Fushun, Liaoning 113000, People's R…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Neuroprotective Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Liaoning Province Livelihood Science and Technology Program.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system that occurs in old age and pre-aging, characterized by progressive cognitive dysfunction and behavioral impairment. Salidroside (Sal) is a phenylpropanoid mainly isolated from Rhodiola species with various pharmacological effects. However, the exact anti-AD mechanism of Sal has not been clearly elucidated. This meta-analysis aims to investigate the possible mechanisms by which Sal exerts its anti-AD effects by evaluating behavioral indicators and biochemical characteristics. A total of 20 studies were included, and the results showed that the Sal treatment significantly improved behavior abnormalities in AD animal models. With regard to neurobiochemical indicators, Sal treatment could effectively increase the antioxidant enzyme superoxide dismutase, decrease the oxidative stress indicator malondialdehyde, and decrease the inflammatory indicators interleukin 1β, interleukin 6, and tumor necrosis factor α. Sal treatment was effective in reducing neuropathological indicators, such as amyloid-β levels and the number of apoptotic cells. When the relevant literature on the treatment of rodent AD models is combined with Sal, the therapeutic potential of Sal through multiple mechanisms was confirmed. However, further confirmation by higher quality studies, larger sample sizes, and more comprehensive outcome evaluations in clinical trials is needed in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Seventh Clinical College of China Medical University, 24 Central Street, Xinfu District, Fushun, Liaoning 113000, People's Republic of China.
- Department of Neurology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, Liaoning 110000, People's Republic of China.
ORCID-Profile: Jianfei Nao, Xiaoyu Dong
Förderung
- Liaoning Province Livelihood Science and Technology Program
Zitieren
APA
Zhang, N., Nao, J., & Dong, X. (2023). Neuroprotective Mechanisms of Salidroside in Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.3c06672
Vancouver
Zhang N, Nao J, Dong X. Neuroprotective Mechanisms of Salidroside in Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies. Journal of Agricultural and Food Chemistry. 2023. doi:10.1021/acs.jafc.3c06672
BibTeX
@article{Zhang2023,
author = {Zhang, Nan and Nao, Jianfei and Dong, Xiaoyu},
title = {Neuroprotective Mechanisms of Salidroside in Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies},
journal = {Journal of Agricultural and Food Chemistry},
year = {2023},
doi = {10.1021/acs.jafc.3c06672}
}
EUVIMED